These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28958623)

  • 1. Identification of selective 8-(piperidin-4-yloxy)quinoline sulfone and sulfonamide histamine H
    Procopiou PA; Ford AJ; Gore PM; Hancock AP; Hodgson ST; Holmes DS; Looker BE; Vile S; Clark KL; Saunders KA; Slack RJ; Watts CJ
    Bioorg Med Chem Lett; 2017 Nov; 27(21):4914-4919. PubMed ID: 28958623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The discovery of quinoline based single-ligand human H
    Procopiou PA; Ancliff RA; Gore PM; Hancock AP; Hodgson ST; Holmes DS; Keeling SP; Looker BE; Parr NA; Rowedder JE; Slack RJ
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5855-5859. PubMed ID: 27866818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.
    Procopiou PA; Browning C; Buckley JM; Clark KL; Fechner L; Gore PM; Hancock AP; Hodgson ST; Holmes DS; Kranz M; Looker BE; Morriss KM; Parton DL; Russell LJ; Slack RJ; Sollis SL; Vile S; Watts CJ
    J Med Chem; 2011 Apr; 54(7):2183-95. PubMed ID: 21381763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can human allergy drug fexofenadine, an antagonist of histamine (H
    Sader S; Cai J; Muller ACG; Wu C
    J Mol Graph Model; 2017 Aug; 75():106-116. PubMed ID: 28544909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical efficacy and safety pharmacology of SUN-1334H, a potent orally active antihistamine agent.
    Mandhane SN; Ayer UB; Midha AS; Rao CT; Rajamannar T
    Drugs R D; 2008; 9(2):93-112. PubMed ID: 18298128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of Phthalazinone Amide Histamine H
    Procopiou PA; Ford AJ; Gore PM; Looker BE; Hodgson ST; Holmes DS; Vile S; Clark KL; Saunders KA; Slack RJ; Rowedder JE; Watts CJ
    ACS Med Chem Lett; 2017 May; 8(5):577-581. PubMed ID: 28523114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterisation of the duration of action of the histamine-1 receptor antagonist azelastine.
    Slack RJ; Hart AD; Luttmann MA; Clark KL; Begg M
    Eur J Pharmacol; 2011 Nov; 670(2-3):586-92. PubMed ID: 21946109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desloratadine citrate disodium injection, a potent histamine H(1) receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades.
    Chen M; Xu S; Zhou P; He G; Jie Q; Wu Y
    Eur J Pharmacol; 2015 Nov; 767():98-107. PubMed ID: 26455479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia.
    Moree WJ; Li BF; Zamani-Kord S; Yu J; Coon T; Huang C; Marinkovic D; Tucci FC; Malany S; Bradbury MJ; Hernandez LM; Wen J; Wang H; Hoare SR; Petroski RE; Jalali K; Yang C; Sacaan A; Madan A; Crowe PD; Beaton G
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5874-8. PubMed ID: 20800486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.
    Procopiou PA; Browning C; Gore PM; Lynn SM; Richards SA; Slack RJ; Sollis SL
    Bioorg Med Chem; 2012 Oct; 20(20):6097-108. PubMed ID: 22985961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of new histamine H1 receptor antagonists.
    Simons FE; Simons KJ
    Clin Pharmacokinet; 1999 May; 36(5):329-52. PubMed ID: 10384858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
    Wober W; Diez Crespo CD; Bähre M
    Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of thromboxane A2 and histamine in experimental allergic rhinitis of guinea pigs.
    Yamasaki M; Matsumoto T; Fukuda S; Nakayama T; Nagaya H; Ashida Y
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1471-9. PubMed ID: 9067337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
    Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
    Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.
    Huang C; Moree WJ; Zamani-Kord S; Li BF; Tucci FC; Malany S; Wen J; Wang H; Hoare SR; Yang C; Madan A; Crowe PD; Beaton G
    Bioorg Med Chem Lett; 2011 Feb; 21(3):947-51. PubMed ID: 21232954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP(4) receptor.
    Burch JD; Belley M; Fortin R; Deschênes D; Girard M; Colucci J; Farand J; Therien AG; Mathieu MC; Denis D; Vigneault E; Lévesque JF; Gagné S; Wrona M; Xu D; Clark P; Rowland S; Han Y
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2048-54. PubMed ID: 18291643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of novel histamine H1 antagonists: indolylpiperidinyl benzoic acid derivatives.
    Fonquerna S; Miralpeix M; Pagès L; Puig C; Cardús A; Antón F; Cárdenas A; Vilella D; Aparici M; Calaf E; Prieto J; Gras J; Huerta JM; Warrellow G; Beleta J; Ryder H
    J Med Chem; 2004 Dec; 47(25):6326-37. PubMed ID: 15566302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New H1/H3 antagonists for treating allergic rhinitis: WO2010094643.
    Norman P
    Expert Opin Ther Pat; 2011 Mar; 21(3):425-9. PubMed ID: 21342057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilastine as a potential treatment in allergic rhinitis.
    Kowal K; DuBuske L
    Am J Rhinol Allergy; 2014; 28(4):312-6. PubMed ID: 25197918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.